NCT06210386

Brief Summary

The optimal noninvasive management of acute hypoxemic respiratory failure is debated. Helmet noninvasive ventilation may be more effective than facemask noninvasive ventilation for these patients. Putatitve benefits of helmet use are the possibility to apply significantly higher positive end-expiratory pressure without air leaks and with good patient's comfort. In this randomized crossover study, the investigators will assess the physiological effects of helmet compared to facemask noninvasive ventilation, with the latter applied with different ventilator settings (similar to or different from helmet settings).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 2, 2024

Completed
16 days until next milestone

First Posted

Study publicly available on registry

January 18, 2024

Completed
1 day until next milestone

Study Start

First participant enrolled

January 19, 2024

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2025

Completed
Last Updated

September 30, 2025

Status Verified

September 1, 2025

Enrollment Period

1.5 years

First QC Date

January 2, 2024

Last Update Submit

September 29, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Inspiratory effort

    negative deflection in esophageal pressure

    1 hour

  • End-expiratory lung impedance

    Electrical-impedance derived end-expiratory lung volume

    1 hour

Secondary Outcomes (12)

  • Tidal volume

    1 hour

  • Work of breathing

    1 hour

  • Respiratory rate

    1 hour

  • Dynamic transpulmonary driving pressure

    1 hour

  • Compliance

    1 hour

  • +7 more secondary outcomes

Study Arms (3)

Helmet noninvasive ventilation

EXPERIMENTAL

1-hour treatment with helmet noninvasive ventilation (PEEP 12 cmH2O + pressure support 10 cmH2O).

Device: Noninvasive ventilation

Facemask noninvasive ventilation (facemask settings)

ACTIVE COMPARATOR

1-hour treatment with facemask noninvasive ventilation (PEEP 5 cmH2O + pressure support 10 cmH2O).

Device: Noninvasive ventilation

Facemask noninvasive ventilation (helmet settings)

ACTIVE COMPARATOR

1-hour treatment with facemask noninvasive ventilation (PEEP 12 cmH2O + pressure support 10 cmH2O).

Device: Noninvasive ventilation

Interventions

noninvasive ventilation

Facemask noninvasive ventilation (facemask settings)Facemask noninvasive ventilation (helmet settings)Helmet noninvasive ventilation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Acute hypoxemic respiratory failure and PaO2/FiO2\<200 mmHg
  • PaCO2\<45 mmHg
  • Respiratory failure not caused by exacerbation of chronic pulmonary disease, cardiac failure or fluid overload

You may not qualify if:

  • Pregnancy
  • Contraindication to helmet or facemask noninvasive ventilation
  • Contraindication to esophageal manometry
  • Contraindication to electrical-impedance tomography monitoring
  • Recent surgery involving the abdomen or the thorax
  • Pneumothorax or documented barotrauma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondazione Policlinico Universitaro A. Gemelli IRCCS

Rome, Italy

Location

MeSH Terms

Conditions

Respiratory Insufficiency

Interventions

Noninvasive Ventilation

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Respiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Study Officials

  • Domenico L. Grieco, MD

    Fondazione Policlinico A. Gemelli IRCCS

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Crossover randomized trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 2, 2024

First Posted

January 18, 2024

Study Start

January 19, 2024

Primary Completion

July 31, 2025

Study Completion

September 15, 2025

Last Updated

September 30, 2025

Record last verified: 2025-09

Locations